Skip to main content

Table 1 Detail parameters of both groups.

From: Comparative study of sequential intravesical chemotherapy using gemcitabine and mitomycin C with mitomycin C alone for non-muscle invasive bladder carcinoma- a randomized trial

Parameters

Group A

Group B

P value

 

(MMC+Gemcitabine)

(MMC)

 

Total patients

102

96

NS+

Male

81

78

NS+

Female

21

19

NS+

Age

65.7±9.8 yrs

63.9±8.9 yrs

NS+

Mean Duration of follow up

36 months

36 months

 

Mean size of tumor <2cm

63

58

NS+

Mean sixe of tume >2 cm

39

38

NS+

Stage Ta

60

58

NS+

Stage T1

42

38

NS+

Grade 1

19

17

NS+

Grade 2

63

61

NS+

Grade 3

20

18

NS+

Previous treatment with BCG

All

All

 

Aim of complete response

100%

100%

 

Actual complete response

83.67% (82)

65.6% (63)

0.001*

Recurrence %

12.2% (12)

25.3% (16)

0.001*

Recurrence

22±6.16 months

14.5±8.26 months

0.001*

Recurrence range in months

8-36 months

4-14 months

 
  1. Values are presented as mean (+/- standard devitation)
  2. Group A: Gemcitabine & Mitomycin (MMC+Gentamycin)
  3. Group B: Mitomycin C(MMS)
  4. *Statistical significance was analyzed by student t-test
  5. +Statistical significance was analyzed by the chi-square test.